Defence is the Best Attack: Immuno-Oncology Breakthroughs

The target audience for this conference is basic and translational scientists and clinicians, both senior and young investigators that want to have a broad and detailed overview of the most recent advances in the field of immunotherapy.

Need more targetted audience? 90% OFF.

PROMOTE NOW
Quick Links
Resources
The Conference Alerts

If you have any suggestion / complain to improve this community, please write us - [email protected]